Future prospective trials should further investigate the relationship between HPV/P16 status and PD-L1 expression, and if HPV status affects ORR or prognosis in ICI-treated SCCHN patients (cfr. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.